RECRUITING

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

Description

The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort. Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.

Conditions

Subarachnoid; Hemorrhage, NontraumaticHeadache
Talk to us

Related Conditions:

Subarachnoid; Hemorrhage, NontraumaticHeadache

Study Overview

On this page

Study Details

Study overview

The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort. Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.

Lidocaine Infusion As A Treatment Modality For Headache Following Non-Traumatic Subarachnoid Hemorrhage: A Prospective, Single-Center, Observational Cohort Study

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

Condition
Subarachnoid; Hemorrhage, Nontraumatic
Intervention / Treatment

-

Contacts and Locations

Wichita

Ascension Via Christi St. Francis, Wichita, Kansas, United States, 67214

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients \> 18 years;
  • * Have a favorable neurological status defined as Hunt and Hess score ≤ 3 (as it accounts for patient awareness);
  • * Can communicate numeric pain scores;
  • * Are diagnosed with non-traumatic subarachnoid hemorrhage
  • * The patient is diagnosed with traumatic subarachnoid hemorrhage;
  • * If the patient is \< 18 years of age;
  • * If numeric pain scores could not be captured for \> 3 days of hospitalization;
  • * If the patient had a prior aneurysm;
  • * Chronic pain not associated with non-traumatic subarachnoid hemorrhage diagnosis;
  • * A disability before the stroke (\> 2 on modified Rankin Scale score);
  • * A Hunt and Hess score \> 3;
  • * Contraindications to lidocaine (significant cardiac disease, arrhythmia, seizures, previous allergic reaction to lidocaine

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Fernando Salgado, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2028-07